Burden and cost of multiple sclerosis in Brazil.

by Gisela Kobelt, Vanessa Teich, Marcela Cavalcanti, Ana Maria Canzonieri
Published 2019-01-01

Real-Life Outcome in Multiple Sclerosis in the Czech Republic

by Gisela Kobelt, Linus Jönsson, Miluse Pavelcova, Eva Kubala Havrdová
Published 2019-01-01

Achieving equal and timely access to innovative anticancer drugs in the European Union (EU): summary of a multidisciplinary CECOG-driven roundtable discussion with a focus on Easte...

by Nils Wilking, Anna Bucsics, Lidlija Kandolf Sekulovic, Gisela Kobelt, Andrea Laslop, Lydia Makaroff, Alexander Roediger, Christoph Zielinski
Published 2019-11-01

Factors influencing daily treatment choices in multiple sclerosis: practice guidelines, biomarkers and burden of disease

by Thomas Berger, Monika Adamczyk-Sowa, Tünde Csépány, Franz Fazekas, Tanja Hojs Fabjan, Dana Horáková, Alenka Horvat Ledinek, Zsolt Illes, Gisela Kobelt, Saša Šega Jazbec, Eleonóra Klímová, Fritz Leutmezer, Konrad Rejdak, Csilla Rozsa, Johann Sellner, Krzysztof Selmaj, Pavel Štouracˇ, Jarmila Szilasiová, Peter Turcˇáni, Marta Vachová, Manuela Vanecková, László Vécsei, Eva Kubala Havrdová
Published 2020-12-01